Cargando…
Platelet trends after Covid‐19 vaccination in patients with chronic or persistent immune thrombocytopenia
Autores principales: | Jiang, Debbie, Portuguese, Andrew Jay, Weatherford, Amanda, Garcia, David, Gernsheimer, Terry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616807/ https://www.ncbi.nlm.nih.gov/pubmed/34619804 http://dx.doi.org/10.1002/ajh.26366 |
Ejemplares similares
-
Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2023) -
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
por: Portuguese, Andrew Jay, et al.
Publicado: (2021) -
Rilzabrutinib versus placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study
por: Kuter, David J., et al.
Publicado: (2023) -
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
por: Appelbaum, Jacob, et al.
Publicado: (2022) -
Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
por: Al‐Samkari, Hanny, et al.
Publicado: (2022)